Skip to content

Gamification Effects on the 6-Minute Walk Test in Children

Effect of Gamification on 6-Minute Walk Test Performance and Engagement in Pediatric Neuromuscular Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07216339
Enrollment
20
Registered
2025-10-14
Start date
2026-06-12
Completion date
2027-06-30
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases in Children

Keywords

Gamification, Walk Test

Brief summary

The goal of this study is to learn if adding a game to the 6-minute walk test for children with neuromuscular disorders will increase enjoyment and motivation to complete the test.

Interventions

OTHERStandard 6MWT

ATS-standard instructions, no electronic system; Conducted in hallway measuring total length of 90ft (27.4 meters). Patients will walk down-and-back. A seated rest period of ≥10 min separates the two tests to minimize fatigue carry-over.

OTHERGamified 6MWT

identical course but child carries a RFID tag; at each lap the child taps an on an RFID reader, awarding a point and leveling-up an on-screen avatar; Conducted in hallway measuring total length of 90ft (27.4 meters). Patients will walk down-and-back.A seated rest period of ≥10 min separates the two tests to minimize fatigue carry-over.

Sponsors

David Toupin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of, or active evaluation for, a neuromuscular disorder * Able to ambulate (with or without usual orthoses/assistive device) sufficiently to attempt a 6-minute walk. * Note: Acceptable if the patient needs to take breaks or sit during the test. Those unable to finish are counted as protocol deviations, not exclusions. * Medically stable on the test day (no acute illness or recent surgery that would contraindicate moderate exercise). * Child able to understand simple instructions in English and provide assent (if applicable based upon age and developmental level); parent/guardian able to provide consent in English.

Exclusion criteria

* Non-ambulatory or unsafe to attempt walking as judged by the treating physician. * Severe cognitive/behavioral impairment that precludes following instructions. * Acute cardiopulmonary, orthopedic, or other medical condition that makes walking unsafe on the test day. * Non-English-speaking family (materials are available only in English for this pilot). * Any child/parent who declines consent/assent or withdraws at any time.

Design outcomes

Primary

MeasureTime frameDescription
Change in 6 minute walk distanceBaseline and post intervention (approximately 20 minutes)Participants will walk back and forth in the clinic hallway for 6 minutes and distance will be recorded in meters

Secondary

MeasureTime frameDescription
Change in Children's OMNI Rate of Perceived Exertion (RPE) ScaleBaseline and post intervention (approximately 20 minutes)The OMNI RPE scale is a visual and numerical tool from 0-10 that helps individuals subjectively gauge the intensity of walking or running activity, with 0 representing no effort and 10 being maximal exertion.
Change in Physical Activity Enjoyment Scale (PACES)Baseline and post intervention (approximately 20 minutes)The Physical Activity Enjoyment Scale (PACES) consists of 8 questions scored on a scale from 1 to 7, with a maximum score of 56 and a minimum score of 8. Higher scores indicate greater enjoyment of physical activity.
Recruitment Rate9 monthspercent of eligible participants successfully recruited in the study
Test completion rate9 monthsnumber of walk tests successfully completed compared to overall number of walk tests

Countries

United States

Contacts

CONTACTDavid N Toupin, MD
d.n.toupin@uky.edu859-218-1900
PRINCIPAL_INVESTIGATORDavid N Toupin, MD

University of Kentucky

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026